Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase NA 7Phase 1/2 7Phase 3 5Phase 1 3Phase 4 1Phase 2/3 1

Status

Completed 14Terminated 9Recruiting 9Not yet recruiting 7Unknown 5Active not recruiting 5Withdrawn 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 5

Conditions

Leukemia, Myeloid, Acute 5Recurrence 1Leukemia 1

Interventions

Cisplatin 129Radiotherapy 94Carboplatin 82Fluorouracil 77Paclitaxel 76Cyclophosphamide 76Gemcitabine 71Capecitabine 66Docetaxel 64Doxorubicin 59Oxaliplatin 57Etoposide 57Leucovorin 48Vincristine 46Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Pemetrexed 27Neoadjuvant Therapy 26Irinotecan 25Tamoxifen 24Prednisone 23Methotrexate 21Rituximab 19Vinorelbine 18Radiotherapy, Intensity-Modulated 18Peripheral Blood Stem Cell Transplantation 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Azacitidine × Clear all
NCT06073730 2023-10-10

Viale-a

The Second Affiliated Hospital of Kunming Medical University

Phase 3 Unknown
154 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05457361 2022-07-14

VAH Versus VA for Salvage Therapy of R/R-AML

Nanfang Hospital, Southern Medical University

Phase 3 Unknown
162 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04490707 2022-03-24

Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML

Zhongda Hospital

Phase 3 Unknown
60 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04722952 2021-12-03

PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine,Cytarabine, G-CSF for Refractory or Relapsed AML

The First Affiliated Hospital of Soochow University

Phase 3 Unknown
30 enrolled
Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute

NCT04716114 2021-11-02

ALIVE

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 3 Unknown
315 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡